DR FILL Trademark

Trademark Overview


On Wednesday, November 18, 2020, a trademark application was filed for DR FILL with the United States Patent and Trademark Office. The USPTO has given the DR FILL trademark a serial number of 90327437. The federal status of this trademark filing is REGISTERED as of Tuesday, March 1, 2022. This trademark is owned by C.L PHARM.CO., LTD.. The DR FILL trademark is filed in the Pharmaceutical Products category with the following description:

Health food supplements, namely, health functional food containing crustacean skin or mollusk bone extract; Pharmaceutical preparations for health care for treating erectile dysfunction; Pharmaceutical preparations for health care for treating allergic rhinitis; Pharmaceutical preparations for health care for treating colds; Pharmaceutical preparations for health care for treating pain; Pharmaceutical preparations for health care for treating insomnia; Pharmaceutical preparations for health care for treating dementia; Pharmaceutical preparations for health care for treating indigestion; Pharmaceutical preparations for health care for treating high blood pressure; Pharmaceutical preparations for health care for treating hyperlipidemia; Pharmaceutical preparations for health care for treating diabetes; Pharmaceutical preparations for health care for treating neurasthenia; Pharmaceutical preparations for health care for treating headache; Pharmaceutical preparations for health care for tr...
dr fill

General Information


Serial Number90327437
Word MarkDR FILL
Filing DateWednesday, November 18, 2020
Status700 - REGISTERED
Status DateTuesday, March 1, 2022
Registration Number6656405
Registration DateTuesday, March 1, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 14, 2021

Trademark Statements


Description of MarkThe mark consists of a stylized, stacked wording "DR" over "FILL" in gray; at upper right appears the design of a plus sign comprised of a blue vertical wavy band, bisected by a green horizontal wavy band; the color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Goods and ServicesHealth food supplements, namely, health functional food containing crustacean skin or mollusk bone extract; Pharmaceutical preparations for health care for treating erectile dysfunction; Pharmaceutical preparations for health care for treating allergic rhinitis; Pharmaceutical preparations for health care for treating colds; Pharmaceutical preparations for health care for treating pain; Pharmaceutical preparations for health care for treating insomnia; Pharmaceutical preparations for health care for treating dementia; Pharmaceutical preparations for health care for treating indigestion; Pharmaceutical preparations for health care for treating high blood pressure; Pharmaceutical preparations for health care for treating hyperlipidemia; Pharmaceutical preparations for health care for treating diabetes; Pharmaceutical preparations for health care for treating neurasthenia; Pharmaceutical preparations for health care for treating headache; Pharmaceutical preparations for health care for treating gout; Pharmaceutical preparations for health care for treating asthma; Pharmaceutical preparations for health care for treating cancer pain; Pharmaceutical preparations for health care for treating schizophrenia; Pharmaceutical preparations for health care for treating tobaccoism; Pharmaceutical preparations for health care for treating intestinal bacteria; Pharmaceutical preparations for health care for treating respiratory diseases and disorders; Pharmaceutical preparations for health care for treating peptic ulcer; Pharmaceutical preparations for health care for treating intestinal disorders; Health food supplements, namely, health functional food mainly based on nuts; Health food supplements, namely, health functional food mainly based on fruit; Dietary supplements for animals; Medicines for animals, namely, medicinal preparations for treating heart failure; Medicines for animals, namely, medicinal preparations for treating arthritis; Medicines for animals, namely, medicinal preparations for treating heart worm; Medicines for animals, namely, medicinal preparations for treating parasite; Medicines for animals, namely, medicinal preparations for treating parasitic worms; Medicines for animals, namely, medicinal preparations for treating skin conditions; Medicines for animals, namely, medicinal preparations for treating nausea; Medicines for animals, namely, medicinal preparations for treating hyperadrenocorticism; Health food supplements made principally of minerals; Health food supplements, namely, health functional food containing mushroom extract; Health food supplements, namely, health functional food mainly based on mushroom; Health food supplements, namely, health functional food consisting primarily of vitamin, namely, vitamin supplements; Health food supplements, namely, health functional food containing fermented plant extracts; Veterinary substances and preparations, namely, veterinary preparations for treatment of heart failure, veterinary preparations for treatment of arthritis, veterinary preparations for treatment of heart worm, veterinary preparations for treatment of parasite, veterinary preparations for treatment of parasitic worms, veterinary preparations for treatment of skin conditions, veterinary preparations for treatment of nausea, and veterinary preparations for treatment of hyperadrenocorticism; Propolis for pharmaceutical purposes; Health food supplements, namely, health functional food mainly based on fish and shellfish; Propolis for medicinal or therapeutic purposes; Drugs for medical purposes, namely, medicinal preparations for treating erectile dysfunction, medicinal preparations for treating allergic rhinitis, medicinal preparations for treating colds, medicinal preparations for treating pain, medicinal preparations for treating insomnia, medicinal preparations for treating dementia, medicinal preparations for treating indigestion, medicinal preparations for treating high blood pressure, medicinal preparations for treating hyperlipidemia, medicinal preparations for treating diabetes, medicinal preparations for treating neurasthenia, medicinal preparations for treating headache, medicinal preparations for treating gout, medicinal preparations for treating asthma, medicinal preparations for treating cancer pain, medicinal preparations for treating schizophrenia, medicinal preparations for treating tobaccoism, medicinal preparations for treating intestinal bacteria, medicinal preparations for treating respiratory diseases and disorders, medicinal preparations for treating peptic ulcer, and medicinal preparations for treating intestinal disorders; Pharmaceuticals, namely, pharmaceutical preparations for treating erectile dysfunction, pharmaceutical preparations for treating allergic rhinitis, pharmaceutical preparations for treating colds, pharmaceutical preparations for treating pain, pharmaceutical preparations for treating insomnia, pharmaceutical preparations for treating dementia, pharmaceutical preparations for treating indigestion, pharmaceutical preparations for treating high blood pressure, pharmaceutical preparations for treating hyperlipidemia, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating neurasthenia, pharmaceutical preparations for treating headache, pharmaceutical preparations for treating gout, pharmaceutical preparations for treating asthma, pharmaceutical preparations for treating cancer pain, pharmaceutical preparations for treating schizophrenia, pharmaceutical preparations for treating tobaccoism, pharmaceutical preparations for treating intestinal bacteria, pharmaceutical preparations for treating respiratory diseases and disorders, pharmaceutical preparations for treating peptic ulcer, and pharmaceutical preparations for treating intestinal disorders; Medicines for human purposes, namely, analgesics, nervines, antiemetics, hypnotic sedatives, anti-inflammatory and antipyretic preparations, psychotropic agents, medicines for acting on the central nervous system, antihistamines, depressants, medicines for strengthening blood vessels, vasoconstrictors, vasohypotonic, cough expectorants, antacids, cholagogues, medicines for alleviating constipation, enema preparations, androgen preparations, chemosterilants, and antidiabetic preparations; Health food supplements, namely, health functional food mainly based on vegetable; Health food supplements for therapeutic purposes; Propolis dietary supplements; Health food supplements, namely, health functional food containing seaweed extract; Health food supplements, namely, health functional food containing red ginseng extract
Indication of Colors claimedThe color(s) green, blue and gray is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameC.L PHARM.CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeoul 04788
KR

Party NameC.L PHARM.CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 04788
KR

Party NameC.L PHARM.CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 04788
KR

Trademark Events


Event DateEvent Description
Tuesday, March 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 10, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 8, 2021DATA MODIFICATION COMPLETED
Monday, November 8, 2021ASSIGNED TO LIE
Saturday, November 6, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, November 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 17, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 17, 2021NON-FINAL ACTION E-MAILED
Monday, May 17, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 11, 2021NON-FINAL ACTION E-MAILED
Tuesday, May 11, 2021NON-FINAL ACTION WRITTEN
Thursday, April 29, 2021ASSIGNED TO EXAMINER
Friday, January 22, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 21, 2020NEW APPLICATION ENTERED IN TRAM